Free Trial
TSE:QIPT

Quipt Home Medical (QIPT) Stock Price, News & Analysis

Quipt Home Medical logo
C$4.75 +0.15 (+3.26%)
As of 01/31/2025 04:00 PM Eastern

About Quipt Home Medical Stock (TSE:QIPT)

Key Stats

Today's Range
C$4.57
C$4.75
50-Day Range
C$3.35
C$4.75
52-Week Range
C$3.28
C$6.70
Volume
23,683 shs
Average Volume
18,188 shs
Market Capitalization
C$204.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$8.75
Consensus Rating
Buy

Company Overview

Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily & Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea & PAP Treatment.

Quipt Home Medical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
27th Percentile Overall Score

QIPT MarketRank™: 

Quipt Home Medical scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Quipt Home Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Quipt Home Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Quipt Home Medical's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Quipt Home Medical is -27.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Quipt Home Medical is -27.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Quipt Home Medical has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for QIPT.
  • Dividend Yield

    Quipt Home Medical does not currently pay a dividend.

  • Dividend Growth

    Quipt Home Medical does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for QIPT.
  • News Sentiment

    Quipt Home Medical has a news sentiment score of -0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Quipt Home Medical this week, compared to 0 articles on an average week.
  • Search Interest

    Only 7 people have searched for QIPT on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Quipt Home Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.88% of the stock of Quipt Home Medical is held by insiders.

  • Percentage Held by Institutions

    50.10% of the stock of Quipt Home Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Quipt Home Medical's insider trading history.
Receive QIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quipt Home Medical and its competitors with MarketBeat's FREE daily newsletter.

QIPT Stock News Headlines

Quipt Home Medical price target lowered to C$7 from C$7.50 at Stifel
Quipt Home Medical price target lowered to $6 from $7 at Benchmark
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chipmaker has struggled this year, facing increased competition and regulatory pressure.
Stifel Nicolaus Reaffirms Their Buy Rating on Quipt Home Medical (QIPT)
Top AI Pick: Quipt Home Medical Corp.
See More Headlines

QIPT Stock Analysis - Frequently Asked Questions

Quipt Home Medical's stock was trading at C$4.38 on January 1st, 2025. Since then, QIPT stock has increased by 8.4% and is now trading at C$4.75.
View the best growth stocks for 2025 here
.

Shares of QIPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quipt Home Medical investors own include Block (SQ), AbCellera Biologics (ABCL), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), ASML (ASML), Broadcom (AVGO) and Booking (BKNG).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
Healthcare
CIK
N/A
Fax
N/A
Employees
800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$8.75
High Stock Price Target
C$10.00
Low Stock Price Target
C$7.50
Potential Upside/Downside
+84.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
C$-4,980,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$244.23 million
Book Value
C$2.55 per share

Miscellaneous

Free Float
N/A
Market Cap
C$204.68 million
Optionable
Not Optionable
Beta
1.01
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (TSE:QIPT) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners